Month: April 2017
-
Cancer Gene Therapy Company Raises $85M in IPO
A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering.
-
Factors IDed Boosting Post-Surgical Opioid Risk
An analysis of insurance claims identifies risk factors behind a sizeable number of people undergoing surgery becoming persistent users of opioid pain drugs long after their procedures.
-
Succeeding Online
If your business isn’t online, you’re already a million steps behind.
-
Corn, Shellfish Ingredients Enable DNA Vaccine Pills
Biomaterials researchers discovered substances from corn and shellfish can package genetic material to pass through the digestive system, making possible vaccines as pills rather than injections.
-
FDA, Emulate to Test Organs-on-Chips for Drug Toxins
A joint venture between Food and Drug Administration and a developer of chip devices simulating human organs, is evaluating the chips as a way to test new drugs for toxic effects.
-
Eureka! Scientific Discoveries That Shaped Business
New tech is always going to have an impact on marketing, but it’s how that tech is used scientifically that has lead to the greatest advancement.
-
NIH Funds Drug-Resistant Malaria Therapy Trial
An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments.
-
Phones, Algorithms Boost Adherence to Stroke Meds
Results from a clinical trial show a smartphone-based remote monitoring program helps stroke patients stay on their blood clot medications and improve their health.
-
Solving The Minefield Of Disgruntled Workers
Solving the minefield of disgruntled workers doesn’t always have to involve a heated debate.
-
Student Project Leads to Medical Device Start-Up
A group of engineering and business students developing an imaging device that quickly finds veins for blood draws is starting a company to take the device to market.